Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Liabilities (2016 - 2025)

CV Sciences (CVSI) has disclosed Total Liabilities for 14 consecutive years, with $5.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 10.4% to $5.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, down 10.4% year-over-year, with the annual reading at $5.5 million for FY2025, 10.4% down from the prior year.
  • Total Liabilities hit $5.5 million in Q4 2025 for CV Sciences, up from $5.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $18.7 million in Q1 2021 to a low of $5.5 million in Q3 2025.
  • Historically, Total Liabilities has averaged $9.6 million across 5 years, with a median of $6.3 million in 2023.
  • Biggest five-year swings in Total Liabilities: grew 10.81% in 2022 and later plummeted 56.84% in 2023.
  • Year by year, Total Liabilities stood at $14.5 million in 2021, then dropped by 6.95% to $13.5 million in 2022, then crashed by 53.4% to $6.3 million in 2023, then fell by 2.62% to $6.1 million in 2024, then fell by 10.4% to $5.5 million in 2025.
  • Business Quant data shows Total Liabilities for CVSI at $5.5 million in Q4 2025, $5.5 million in Q3 2025, and $6.1 million in Q2 2025.